CVA
LMAT icon

Ceredex Value Advisors’s LeMaitre Vascular LMAT Stock Holding History

Ceredex Value Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-85,130
Closed -$4.38M – 174
2023
Q1 		$4.38M Sell
85,130
-5,100
-6% -$248K 0.07% 155
2022
Q4 		$4.15M Sell
90,230
-1,100
-1% -$51.5K 0.06% 156
2022
Q3 		$4.63M Sell
91,330
-1,787
-2% -$89.3K 0.08% 143
2022
Q2 		$4.24M Buy
+93,117
New +$4.17M 0.06% 143

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Ceredex Value Advisors's LMAT Position: Q2 2023 in Review

Ceredex Value Advisors sold out of LeMaitre Vascular (LMAT) in Q2 2023, closing a stake of 85,130 shares — an estimated $4.38M sold.

Ceredex Value Advisors first reported a position in LMAT in Q2 2022 and held it in 4 quarters. The position peaked at $4.63M in Q3 2022. 212 funds tracked by Wall St. Rank hold LMAT as of Q2 2023.

  • Ceredex Value Advisors reported no remaining LeMaitre Vascular position as of Q2 2023 after selling out during the quarter.
  • Ceredex Value Advisors sold 85,130 LeMaitre Vascular shares in Q2 2023, an estimated $4.38M.
  • Ceredex Value Advisors first reported a position in LeMaitre Vascular in Q2 2022 and held it in 4 quarters.
  • Ceredex Value Advisors's LeMaitre Vascular position peaked at $4.63M in Q3 2022.
  • 212 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2023.

Based on Ceredex Value Advisors's 13F filing for Q2 2023, filed 25 Jul 2023.